Maze Therapeutics (NASDAQ:MAZE) CMO Harold Bernstein Sells 15,000 Shares
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 15,000 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of...
MarketBeat·8h ago
More News
Maze Therapeutics (NASDAQ:MAZE) Sets New 12-Month High - Should You Buy?
Maze Therapeutics (NASDAQ:MAZE) Hits New 12-Month High - Time to Buy...
MarketBeat·2d ago
Maze Therapeutics (NASDAQ:MAZE) Insider Sells $332,025.00 in Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) insider Atul Dandekar sold 7,500 shares of Maze Therapeutics stock in a transaction dated Thursday, January 29th. The stock was sold at an...
MarketBeat·2d ago
Strs Ohio Decreases Stake in Maze Therapeutics, Inc. $MAZE
Strs Ohio cut its position in Maze Therapeutics, Inc. (NASDAQ:MAZE - Free Report) by 61.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·4d ago
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock
Key PointsAmy Bachrodt exercised 5,000 shares and immediately sold them for approximately $227,612 on Jan. 22, 2026...
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 5,000 shares of the company's stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an...
MarketBeat·9d ago
Amy Bachrodt Sells 5,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock
Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 5,000 shares of the firm's stock in a transaction dated Thursday, January 22nd. The shares were sold at an average price...
MarketBeat·10d ago
Maze Therapeutics (NASDAQ:MAZE) Raised to "Hold" at Wall Street Zen
Wall Street Zen raised Maze Therapeutics from a "sell" rating to a "hold" rating in a research report on Sunday...
MarketBeat·11d ago
First Week of March 20th Options Trading For Maze Therapeutics (MAZE)
Investors in Maze Therapeutics Inc (Symbol: MAZE) saw new options begin trading this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Nasdaq News: Markets·15d ago
Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year High - What's Next?
Maze Therapeutics (NASDAQ:MAZE) Reaches New 12-Month High - Still a Buy...